Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Characterisation of candidemia in patients with recent surgery: A 7-year experience.

Orsetti E, Brescini L, Mazzanti S, Trave F, Morroni G, Masucci A, Barchiesi F.

Mycoses. 2019 Nov;62(11):1056-1063. doi: 10.1111/myc.12988. Epub 2019 Sep 9.

PMID:
31421007
2.

Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.

Brescini L, Morroni G, Valeriani C, Castelletti S, Mingoia M, Simoni S, Masucci A, Montalti R, Vivarelli M, Giacometti A, Barchiesi F.

BMC Infect Dis. 2019 Jul 12;19(1):611. doi: 10.1186/s12879-019-4268-9.

3.

Central venous catheter unrelated candidemia influences the outcome of infection in patients with solid tumors.

Orsetti E, Brescini L, Mazzanti S, Trave F, Morroni G, Pocognoli A, Berardi R, Barchiesi F.

Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1499-1505. doi: 10.1007/s10096-019-03578-z. Epub 2019 May 16.

PMID:
31098865
4.

Prevalence and predictors of malignancies in HIV patients: results of a retrospective multicentric Italian cohort.

Mazzotta E, Riccardi N, Tontodonati M, Gabrielli C, Mazzocato S, Mazzetti M, Falasca K, Vecchiet J, Barchiesi F, Francisi D, Siri G, Cenderello G, Parruti G.

Infez Med. 2019 Mar 1;27(1):53-57.

5.

Acute histoplasmosis in immunocompetent travelers: a systematic review of literature.

Staffolani S, Buonfrate D, Angheben A, Gobbi F, Giorli G, Guerriero M, Bisoffi Z, Barchiesi F.

BMC Infect Dis. 2018 Dec 18;18(1):673. doi: 10.1186/s12879-018-3476-z.

6.

High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Staphylococcus aureus Isolates from a Hospital in Central Italy.

Morroni G, Brenciani A, Brescini L, Fioriti S, Simoni S, Pocognoli A, Mingoia M, Giovanetti E, Barchiesi F, Giacometti A, Cirioni O.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01663-18. doi: 10.1128/AAC.01663-18. Print 2018 Dec.

7.

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.

Guinea J, Verweij PE, Meletiadis J, Mouton JW, Barchiesi F, Arendrup MC; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST).

Clin Microbiol Infect. 2019 Jun;25(6):681-687. doi: 10.1016/j.cmi.2018.09.008. Epub 2018 Sep 28. Review.

PMID:
30268672
8.

Estimated burden of fungal infections in Italy.

Bassetti M, Carnelutti A, Peghin M, Aversa F, Barchiesi F, Girmenia C, Pagano L, Sanguinetti M, Tortorano AM, Montagna MT, Viale P, Viscoli C, Denning DW.

J Infect. 2018 Jan;76(1):103-106. doi: 10.1016/j.jinf.2017.07.008. Epub 2017 Aug 3. No abstract available.

PMID:
28780007
9.

Candidemia in the elderly: What does it change?

Barchiesi F, Orsetti E, Mazzanti S, Trave F, Salvi A, Nitti C, Manso E.

PLoS One. 2017 May 11;12(5):e0176576. doi: 10.1371/journal.pone.0176576. eCollection 2017.

10.

Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia.

Tascini C, Sozio E, Di Paolo A, Tintori G, Leonildi A, Bertolino G, Carmassi F, Tagliaferri E, Menichetti F, Barchiesi F.

J Chemother. 2017 Dec;29(6):376-379. doi: 10.1080/1120009X.2017.1289308. Epub 2017 Feb 15.

PMID:
28198656
11.

Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.

Barchiesi F, Montalti R, Castelli P, Nicolini D, Staffolani S, Mocchegiani F, Fiorentini A, Manso E, Vivarelli M.

BMC Infect Dis. 2016 Oct 4;16(1):538.

12.

Factors related to outcome of bloodstream infections due to Candida parapsilosis complex.

Barchiesi F, Orsetti E, Osimani P, Catassi C, Santelli F, Manso E.

BMC Infect Dis. 2016 Aug 9;16:387. doi: 10.1186/s12879-016-1704-y.

13.

Delay of antifungal therapy influences the outcome of invasive aspergillosis in experimental models of infection.

Barchiesi F, Santinelli A, Biscotti T, Greganti G, Giannini D, Manso E.

J Antimicrob Chemother. 2016 Aug;71(8):2230-3. doi: 10.1093/jac/dkw111. Epub 2016 May 26.

PMID:
27231274
14.

Aspergillus spp. invasive external otitis: favourable outcome with a medical approach.

Marchionni E, Parize P, Lefevre A, Vironneau P, Bougnoux ME, Poiree S, Coignard-Biehler H, DeWolf SE, Amazzough K, Barchiesi F, Jullien V, Alanio A, Garcia-Hermoso D, Wassef M, Kania R, Lortholary O, Lanternier F.

Clin Microbiol Infect. 2016 May;22(5):434-7. doi: 10.1016/j.cmi.2015.12.027. Epub 2016 Jan 21.

15.

2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.

Schaufelberger SA, Rosselli M, Barchiesi F, Gillespie DG, Jackson EK, Dubey RK.

Am J Physiol Endocrinol Metab. 2016 Mar 1;310(5):E313-22. doi: 10.1152/ajpendo.00418.2015. Epub 2016 Jan 5.

16.

Antiretroviral therapy management and rationalisation of available resources.

Cirioni O, Castelletti S, Ucciferri C, Falasca K, Orsetti E, Mazzocato S, Valeriani C, Di Campli FM, Barchiesi F, Vecchiet J, Giacometti A.

Infez Med. 2015 Dec;23(4):330-5.

17.

Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014.

Barchiesi F, Orsetti E, Gesuita R, Skrami E, Manso E; Candidemia Study Group.

Infection. 2016 Apr;44(2):205-13. doi: 10.1007/s15010-015-0845-z. Epub 2015 Sep 26.

PMID:
26410297
18.

Prevalence and predictors of malignancies in a polycentric cohort of HIV patients from Italy.

Mazzotta E, Tontodonati M, Gabrielli C, Mazzocato S, Mazzetti M, Falasca K, Cenderello G, Vecchiet J, Barchiesi F, Francisci D, Parruti G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19652. doi: 10.7448/IAS.17.4.19652. eCollection 2014.

19.

Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases.

Barchiesi F, Mazzocato S, Mazzanti S, Gesuita R, Skrami E, Fiorentini A, Singh N.

Liver Transpl. 2015 Feb;21(2):204-12. doi: 10.1002/lt.24032.

20.

Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection.

Brescini L, Orsetti E, Gesuita R, Piraccini F, Marchionni E, Staffolani S, Castelli P, Drenaggi D, Barchiesi F.

Hepat Mon. 2014 Aug 5;14(8):e15426. doi: 10.5812/hepatmon.15426. eCollection 2014 Aug.

21.

Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometry.

Mazzocato S, Orsetti E, Gesuita R, Piraccini F, Drenaggi D, Barchiesi F.

Scand J Infect Dis. 2014 Nov;46(11):797-802. doi: 10.3109/00365548.2014.952245. Epub 2014 Sep 22.

PMID:
25244675
22.

Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature.

Mazzocato S, Marchionni E, Fothergill AW, Sutton DA, Staffolani S, Gesuita R, Skrami E, Fiorentini A, Manso E, Barchiesi F.

Infection. 2015 Apr;43(2):211-5. doi: 10.1007/s15010-014-0668-3. Epub 2014 Jul 31. Review.

PMID:
25078793
23.

In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.

Simonetti O, Silvestri C, Arzeni D, Cirioni O, Kamysz W, Conte I, Staffolani S, Orsetti E, Morciano A, Castelli P, Scalise A, Kamysz E, Offidani AM, Giacometti A, Barchiesi F.

Mycoses. 2014 Apr;57(4):233-9. doi: 10.1111/myc.12148. Epub 2013 Oct 16.

PMID:
26058322
24.

Reply to Ma et al.: osteomyelitis caused by Aspergillus species.

Gabrielli E, Fothergill AW, Brescini L, Sutton DA, Marchionni E, Orsetti E, Staffolani S, Castelli P, Gesuita R, Barchiesi F.

Clin Microbiol Infect. 2014 Oct;20(10):O788. doi: 10.1111/1469-0691.12613. Epub 2014 Mar 26. No abstract available.

25.

Seasonal monitoring of Aedes albopictus: practical applications and outcomes.

Gavaudan S, Duranti A, Barchiesi F, Ruschioni S, Antognini E, Calandri E, Mancini P, Riolo P.

Vet Ital. 2014 Apr-Jun;50(2):109-16.

26.

Osteomyelitis caused by Aspergillus species: a review of 310 reported cases.

Gabrielli E, Fothergill AW, Brescini L, Sutton DA, Marchionni E, Orsetti E, Staffolani S, Castelli P, Gesuita R, Barchiesi F.

Clin Microbiol Infect. 2014 Jun;20(6):559-65. doi: 10.1111/1469-0691.12389. Epub 2013 Oct 15. Review.

27.

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.

Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L, Sanguinetti M, Masciari R, Santantonio T, Andreoni S, Barchiesi F, Pecile P, Farina C, Viale P, Specchia G, Caggiano G, Pagano L.

Infection. 2014 Feb;42(1):141-51. doi: 10.1007/s15010-013-0539-3. Epub 2013 Oct 23.

28.

Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.

Barchiesi F, Spreghini E, Sanguinetti M, Giannini D, Manso E, Castelli P, Girmenia C.

J Antimicrob Chemother. 2013 Nov;68(11):2587-91. doi: 10.1093/jac/dkt232. Epub 2013 Jun 21.

PMID:
23794598
29.

Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individuals.

Orsetti E, Staffolani S, Gesuita R, De Iaco G, Marchionni E, Brescini L, Castelli P, Barchiesi F.

Infection. 2013 Oct;41(5):987-90. doi: 10.1007/s15010-013-0465-4. Epub 2013 May 24.

PMID:
23703287
30.

Intestinal parasitosis: data analysis 2006-2011 in a teaching hospital of Ancona, Italy.

Silvestri C, Greganti G, Arzeni D, Morciano A, Castelli P, Barchiesi F, Cirioni O, Giacometti A.

Infez Med. 2013 Mar;21(1):34-9.

31.
32.

In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.

Spreghini E, Orlando F, Tavanti A, Senesi S, Giannini D, Manso E, Barchiesi F.

J Antimicrob Chemother. 2012 Sep;67(9):2195-202. doi: 10.1093/jac/dks180. Epub 2012 May 25.

PMID:
22635526
33.

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Spreghini E, Orlando F, Sanguinetti M, Posteraro B, Giannini D, Manso E, Barchiesi F.

Antimicrob Agents Chemother. 2012 Mar;56(3):1215-22. doi: 10.1128/AAC.05872-11. Epub 2011 Dec 27.

34.

Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolates.

Cogliati M, Barchiesi F, Spreghini E, Tortorano AM.

Mycopathologia. 2012 Jun;173(5-6):347-57. doi: 10.1007/s11046-011-9467-x. Epub 2011 Sep 16.

PMID:
21922248
35.

Receptor for activated protein kinase C1 regulates cell proliferation by modulating calcium signaling.

Cheng D, Zhu X, Barchiesi F, Gillespie DG, Dubey RK, Jackson EK.

Hypertension. 2011 Oct;58(4):689-95. doi: 10.1161/HYPERTENSIONAHA.111.174508. Epub 2011 Aug 15.

36.

Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.

Grossi PA, Gasperina DD, Barchiesi F, Biancofiore G, Carafiello G, De Gasperi A, Sganga G, Menichetti F, Montagna MT, Pea F, Venditti M, Viale P, Viscoli C, Nanni Costa A.

Transplant Proc. 2011 Jul-Aug;43(6):2463-71. doi: 10.1016/j.transproceed.2011.06.020.

PMID:
21839295
37.

In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp.

Kamysz E, Simonetti O, Cirioni O, Arzeni D, Ganzetti G, Campanati A, Giacometti A, Gabrielli E, Silvestri C, Kamysz W, Offidani A, Barchiesi F.

Peptides. 2011 Jan;32(1):99-103. doi: 10.1016/j.peptides.2010.10.022. Epub 2010 Nov 3.

PMID:
21055432
38.

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

Barchiesi F, Lucchinetti E, Zaugg M, Ogunshola OO, Wright M, Meyer M, Rosselli M, Schaufelberger S, Gillespie DG, Jackson EK, Dubey RK.

Hypertension. 2010 Nov;56(5):964-72. doi: 10.1161/HYPERTENSIONAHA.110.152298. Epub 2010 Oct 4. Erratum in: Hypertension. 2016 May;67(5):e21.

39.

In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.

Spreghini E, Orlando F, Giannini D, Barchiesi F.

J Antimicrob Chemother. 2010 Oct;65(10):2158-63. doi: 10.1093/jac/dkq276. Epub 2010 Jul 28.

PMID:
20667887
40.

Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Baruscotti I, Barchiesi F, Jackson EK, Imthurn B, Stiller R, Kim JH, Schaufelberger S, Rosselli M, Hughes CC, Dubey RK.

Hypertension. 2010 Sep;56(3):397-404. doi: 10.1161/HYPERTENSIONAHA.110.153262. Epub 2010 Jul 19.

41.

Disruption of homocitrate synthase genes in Candida albicans affects growth but not virulence.

Kur K, Gabriel I, Morschhäuser J, Barchiesi F, Spreghini E, Milewski S.

Mycopathologia. 2010 Dec;170(6):397-402. doi: 10.1007/s11046-010-9337-y. Epub 2010 Jun 23.

PMID:
20571912
42.

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

Spreghini E, Orlando F, Santinelli A, Pisa E, Loretelli C, Manso E, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2009 Sep;53(9):4035-9. doi: 10.1128/AAC.00659-09. Epub 2009 Jul 13.

43.

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.

Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, Cirioni O, Gabrielli E, Lenci I, Kamysz W, Kamysz E, Giacometti A, Scalise G, Barchiesi F, Offidani A.

Peptides. 2009 Oct;30(10):1794-7. doi: 10.1016/j.peptides.2009.06.033. Epub 2009 Jul 8.

PMID:
19591887
44.

In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.

Simonetti O, Arzeni D, Ganzetti G, Silvestri C, Cirioni O, Gabrielli E, Castelletti S, Kamysz W, Kamysz E, Scalise G, Offidani A, Barchiesi F.

Br J Dermatol. 2009 Aug;161(2):249-52. doi: 10.1111/j.1365-2133.2009.09166.x. Epub 2009 Apr 29.

PMID:
19438437
45.

In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G.

Med Mycol. 2009 May;47(3):321-6. doi: 10.1080/13693780802641920. Epub 2008 Dec 27.

PMID:
19115137
46.

Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.

Maida CM, Milici ME, Trovato L, Oliveri S, Amodio E, Spreghini E, Scalise G, Barchiesi F.

J Clin Microbiol. 2008 Dec;46(12):4071-4. doi: 10.1128/JCM.01088-08. Epub 2008 Oct 15.

47.

Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.

Spreghini E, Maida CM, Tomassetti S, Orlando F, Giannini D, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2008 Jun;52(6):1929-33. doi: 10.1128/AAC.00130-08. Epub 2008 Apr 7.

48.

In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.

Barchiesi F, Giacometti A, Cirioni O, Arzeni D, Kamysz W, Silvestri C, Licci A, Marigliano A, Della Vittoria A, Nadolski P, Łukasiak J, Scalise G.

J Chemother. 2007 Oct;19(5):514-8.

PMID:
18073150
49.

Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.

Spreghini E, Maida CM, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2008 Feb;52(2):513-7. Epub 2007 Dec 3.

50.

Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.

Milici ME, Maida CM, Spreghini E, Ravazzolo B, Oliveri S, Scalise G, Barchiesi F.

J Clin Microbiol. 2007 Nov;45(11):3529-33. Epub 2007 Aug 29.

Supplemental Content

Loading ...
Support Center